http://archive.fast-edgar.com/20260929/APV28222Z22262G2222S22Z2NQIMYX229282
Filed on: September 29, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-41950
Ryde Group Ltd
Duo Tower, 3 Fraser Street, #08-21
Singapore 189352
+65-9665-3216
(Address of principal executive offices)
Indicate by check mark whether the registrant... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 1-SA
☒ SEMIANNUAL REPORT PURSUANT TO REGULATION A
or
☐ SPECIAL FINANCIAL REPORT PURSUANT TO REGULATION A
For the fiscal semiannual period ended June 30, 2026
Standard Dental Labs Inc.
(Exact Name of Registrant as Specified in Charter)
Nevada 88-0411500
More SEC Filings
View Older Stories-
Form 4 H World Group Ltd For: Sep 26 Filed by: Jin Hui
-
Form 8-K Keros Therapeutics, Inc. For: Sep 29
-
Form 6-K SaverOne 2014 Ltd. For: Sep 29
-
Form 8-A12B DYNEX CAPITAL INC
-
Form SC TO-T/A ACV Auctions Inc. Filed by: COPART INC
-
Form S-3ASR MERCANTILE BANK CORP
-
Form 6-K MINISO Group Holding For: Sep 29
-
Form D/A MCorp a Series of CGF202
-
Form 8-K Imunon, Inc. For: Sep 28
-
Form 8-K TOP Financial Group Ltd For: Sep 25
-
Form 8-K Bloomin' Brands, Inc. For: Sep 25
-
Form 8-K FIRST UNITED CORP/MD/ For: Sep 24
-
Form 8-K Allarity Therapeutics, For: Sep 28
-
Form 8-K SurgePays, Inc. For: Sep 28
-
Form RW Syra Health Corp
-
Form 6-K POWERBANK Corp For: Sep 29
-
Form 8-K ATOSSA THERAPEUTICS, For: Sep 29
-
Form 6-K RoyaLand Co Ltd. For: Sep 29
-
Form 8-K TransDigm Group INC For: Sep 28
-
Form N-23C-2 OFS Credit Company, Inc. For: Sep 29
-
Form 497J Tidal Trust I
-
Form D/A Sensori April 2026 a
-
Form D/A Dart Financial Corp
-
Form D/A Auvi Labs Heinz Ventures
-
Form 485BXT GraniteShares ETF Trust
-
Form 40-17F2 BNY MELLON HIGH YIELD Filed by: BNY MELLON HIGH YIELD STRATEGIES FUND
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds I
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds II, Inc.
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds III
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds IV, Inc.
-
Form NT 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
Form 8-K Unicycive Therapeutics, For: Sep 28
-
Form D/A Declan Odyssey X a Serie
-
Form 8-K SOUNDTHINKING, INC. For: Sep 28
-
Form 485BXT GraniteShares ETF Trust
-
Form 424B2 TORONTO DOMINION BANK
-
Form D/A PRIVATEAIINVESTMENTSVLLC
-
Form 485BXT GraniteShares ETF Trust
-
Form 6-K Charming Medical Ltd For: Sep 29
-
Form 6-K Metalpha Technology Hold For: Sep 29
-
Form 18-K/A ONTARIO PROVINCE OF For: Mar 31
-
Form 6-K Glass House Brands Inc. For: Sep 29
-
Form 6-K Almonty Industries Inc. For: Sep 29
-
Form D VIRELTO LTD.
-
Form 8-K Cartesian Therapeutics, For: Sep 29
-
Form 6-K Central North Airport For: Sep 29
-
Form 6-K One & one Green Technolo For: Jun 30
-
Form 20-F Gamehaus Holdings Inc. For: Jun 30
-
Form 6-K MIXED MARTIAL ARTS GROUP For: Sep 29
-
Form 6-K Optimi Health Corp. For: Sep 29

